Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 150 of 3173 entries
View as:

Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia

Phase: N/A Priority: Normal
NCT ID: NCT00084240 Org: User:
Start: 03/31/04 End: 04/30/05 Due: 04/30/06

A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT00090532 Org: User:
Start: 01/31/04 End: 08/31/06 Due: 08/31/07

Assessment Of Safety Of UK-390,957

Phase: N/A Priority: Normal
NCT ID: NCT00219609 Org: User:
Start: 01/31/05 End: 03/31/06 Due: 03/31/07

To Learn How Different Forms of Study Medicine Are Taken up Into the Blood and the Effect of Food on Study Medicine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06593054 Org: User:
Start: 07/29/24 End: 10/11/24 Due: 10/11/25

Bosutinib For Autosomal Dominant Polycystic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT01233869 Org: User:
Start: 12/31/10 End: 08/31/14 Due: 08/31/15

Special Investigation of COMIRNATY in the Population With Underlying Diseases

Phase: N/A Priority: Normal
NCT ID: NCT04880447 Org: User:
Start: 05/26/21 End: 04/14/22 Due: 04/14/23

A Bioequivalence Study Of 4 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00902187 Org: User:
Start: 05/31/09 End: 06/30/09 Due: 06/30/10

Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT04171141 Org: User:
Start: 11/19/19 End: 11/28/23 Due: 11/28/24

Singe Dose, First in Human Study of PF- 06946860 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03599063 Org: User:
Start: 07/30/18 End: 09/18/19 Due: 09/18/20

A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses Of Vaccine.

Phase: N/A Priority: Normal
NCT ID: NCT02117570 Org: User:
Start: 07/31/14 End: 12/31/15 Due: 12/31/16

A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03529773 Org: User:
Start: 04/18/18 End: 12/28/20 Due: 12/28/21

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Phase: N/A Priority: Normal
NCT ID: NCT01371708 Org: User:
Start: 02/02/12 End: 04/22/16 Due: 04/22/17

A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT00314938 Org: User:
Start: 04/30/06 End: 11/30/07 Due: 11/30/08

A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.

Phase: N/A Priority: Normal
NCT ID: NCT00798434 Org: User:
Start: 06/30/08 End: 09/30/10 Due: 09/30/11

Swedish Ibrance Registries Insights (SIRI)

Phase: N/A Priority: Normal
NCT ID: NCT04654208 Org: User:
Start: 12/15/20 End: 08/31/24 Due: 08/31/25

Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam

Phase: N/A Priority: Normal
NCT ID: NCT00952653 Org: User:
Start: 06/30/10 End: 08/31/10 Due: 08/31/11

Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML

Phase: N/A Priority: Normal
NCT ID: NCT03727750 Org: User:
Start: 07/03/19 End: 04/27/21 Due: 04/27/22

SA4Ag Safety, Tolerability, and Immunogenicity Study in Japanese Adults

Phase: N/A Priority: Normal
NCT ID: NCT02492958 Org: User:
Start: 06/30/15 End: 09/30/16 Due: 09/30/17

Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infants

Phase: N/A Priority: Normal
NCT ID: NCT03765073 Org: User:
Start: 01/14/19 End: 03/04/24 Due: 03/04/25

A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00945672 Org: User:
Start: 08/06/09 End: 06/01/11 Due: 06/01/12

THE EFFECT OF MULTIPLE DOSES OF PF-06835919 ON THE PHARMACOKINETICS OF A SINGLE ORAL MIDAZOLAM DOSE IN HEALTHY PARTICIPANTS

Phase: N/A Priority: Normal
NCT ID: NCT03916406 Org: User:
Start: 04/18/19 End: 06/25/19 Due: 06/25/20

A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00102895 Org: User:
Start: 04/30/05 End: 09/30/05 Due: 09/30/06

A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01240915 Org: User:
Start: 02/28/11 End: 11/30/14 Due: 11/30/15

Effect Of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of PF-06865571 In Subjects With Hepatic Impairment and in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04091061 Org: User:
Start: 10/03/19 End: 04/07/20 Due: 04/07/21

A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00827034 Org: User:
Start: 02/28/09 End: 04/30/09 Due: 04/30/10